mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
0.16 |
0.6 |
mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
UNC1215 |
GDSC1000 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.6 |
mRNA |
QL-X-138 |
GDSC1000 |
pan-cancer |
AAC |
-0.015 |
0.6 |
mRNA |
ELCPK |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.6 |
mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.6 |